Amila L. Orucevic, MD, PhD
Pathologist, Research Director, Professor
Travelling with family, cooking gourmet food, walking, skiing and reading

Pathologist, Research Director, Professor
Travelling with family, cooking gourmet food, walking, skiing and reading
Gender: Female
Languages Spoken:
Bosnian, Croatian, English, Serbian
Clinical Focus:
General surgical pathology with specialty interest in breast pathology, gynecologic pathology, gastrointestinal, liver pathology
Specialties:
Pathology
Medical School
University of Sarajevo Medical School, 1978-1983, Bosnia and Herzegovina
Internships
University Medical Center, University of Sarajevo, 1984, Bosnia and Herzegovina
Residencies
Combined Anatomic and Clinical Pathology, Rush Presbyterian St. Luke's Medical Center, 1998-2002, Chicago, IL
Fellowships
Surgical Pathology Fellowship, Loyola University Medical Center, 2002-2003, Maywood, IL
Other Education
Ph.D. degree, Department of Anatomy, The University of Western Ontario, 1990-1996, London, Ontario, Canada
Board Certifications
The American Board of Pathology in Combined Anatomic Pathology and Clinical Pathology (2002); The Royal College of Physicians and Surgeons of Canada in Anatomic Pathology (2002)
Organizations & Societies
United States and Canadian Academy of Pathology (USCAP) College of American Pathologists (CAP) Fellow of The Royal College of Physicians and Surgeons of Canada Member of the British Association of Gynaecological Pathologists
Publications
Papers: Nomogram update based on TAILORx clinical trial results - Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data, Orucevic A, Bell JL, King M, McNabb AP, Heidel RE, Breast (Edinburgh, Scotland), 2019 May 10;46:116-125. Adenosquamous carcinoma of the anus: An uncommon malignancy presenting a treatment challenge, Johnson M, Casillas M Jr, Orucevic A, The American Surgeon, 2018 Jul 1;84(7):e248-e250. Oncotype DX breast cancer recurrence score can be predicted with a novel nomogram using clinicopathologic data, Orucevic A, Bell JL, McNabb AP, Heidel RE, Breast Cancer Research and Treatment., 2017 May;163(1):51-61. Epub 2017 Feb 27. Evolving trends and influencing factors in mastectomy decisions, Bhat S, Orucevic A, Woody C, Heidel RE, Bell JL, The American Surgeon, 2017 Mar 1;83(3):233-238. A rare case of plasmablastic lymphoma mimicking adenocarcinoma of the sigmoid colon, Kleppe KL, Gray KD, Stancher JA, Duncan LD, Vaughan JW, Orucevic A, The American Surgeon, 2016 Aug;82(8):178-180. case of pancreatic intraductal tubular carcinoma: A rare entity with improved prognosis, Bhat S, McLoughlin JM, Orucevic A, The American Surgeon, 2016 Jul;82(7):654-5. Utilization and impact of 21-gene recurrence score assay for breast cancer in clinical practice across the United States: lessons learned from the 2010 to 2012 National Cancer Data Base analysis, Orucevic A, Heidel RE, Bell JL, Breast Cancer Research and Treatment, 2016 Jun;157(3):427-35. Epub 2016 May 20.
Visiting our main campus? Use the UTMC Way app to get around.